Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Invested Capital (2017 - 2025)

Historic Return on Invested Capital for Vanda Pharmaceuticals (VNDA) over the last 10 years, with Q3 2025 value amounting to 0.2%.

  • Vanda Pharmaceuticals' Return on Invested Capital fell 1400.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 0.06% for FY2024, which is 500.0% down from last year.
  • As of Q3 2025, Vanda Pharmaceuticals' Return on Invested Capital stood at 0.2%, which was down 1400.0% from 0.16% recorded in Q2 2025.
  • Vanda Pharmaceuticals' 5-year Return on Invested Capital high stood at 0.07% for Q3 2021, and its period low was 0.2% during Q3 2025.
  • In the last 5 years, Vanda Pharmaceuticals' Return on Invested Capital had a median value of 0.01% in 2022 and averaged 0.02%.
  • Data for Vanda Pharmaceuticals' Return on Invested Capital shows a peak YoY increase of 300bps (in 2021) and a maximum YoY decrease of -1600bps (in 2021) over the last 5 years.
  • Vanda Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.07% in 2021, then plummeted by -90bps to 0.01% in 2022, then plummeted by -250bps to 0.01% in 2023, then crashed by -509bps to 0.06% in 2024, then tumbled by -223bps to 0.2% in 2025.
  • Its Return on Invested Capital was 0.2% in Q3 2025, compared to 0.16% in Q2 2025 and 0.11% in Q1 2025.